Clinical Trials Browser

INDUSTRY × Infectious Mononucleosis × 90 days × Clear all

NCT05164094 2026-05-06

A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults

Phase 1/2 Active not recruiting

Infectious Mononucleosis, Epstein-Barr Virus Infections